Innate Pharma SA Net Foreign Exchange Gain
Innate Pharma SA (IPHYF) reported Net Foreign Exchange Gain of EUR 5.88 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Other Income
ifrs-full:NetForeignExchangeGain · last filed 2026-04-01
| Period end | Net Foreign Exchange Gain 6 month | Net Foreign Exchange Gain 12 month |
|---|---|---|
| 2025-12-31 | 5.88M EUR 20-F · filed 2026-04-01 | |
| 2024-12-31 | 1.66M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 873.00K EUR 6-K · filed 2024-09-12 | |
| 2023-12-31 | 2.11M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 1.07M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 3.81M EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 3.80M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 4.84M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 2.19M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 3.98M EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 1.93M EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 5.57M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 4.07M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 784.00K EUR 20-F · filed 2020-04-24 |